Gabriel Calzada

Cardiovascular Medical Group, Kaiser Permanente

Papers

2

Total Citations

29

H-Index

2

About

Gabriel Calzada is a head and neck surgeon whose research focuses on advancing minimally invasive treatment paradigms for oropharyngeal cancers, particularly through transoral robotic surgery (TORS). His major contributions center on developing and validating treatment algorithms that integrate staging neck dissection with TORS to optimize outcomes for patients with palatine tonsil squamous cell carcinoma. In his seminal 2017 paper (12 citations), Calzada introduced a novel algorithm designed to identify candidates who can safely receive single-modality TORS, thereby preserving quality of life by avoiding the toxicities of adjuvant radiotherapy. His 2020 comparative study (17 citations) provided critical cost-effectiveness data, demonstrating that TORS offers economic advantages over intensity-modulated radiotherapy (IMRT) for early-stage tonsil cancer. Collectively, his work has helped refine surgical selection criteria and treatment de-escalation strategies in head and neck oncology. Calzada’s research bridges surgical innovation with health economics, offering evidence that robotic surgery can be both clinically effective and resource-efficient. His contributions are particularly valuable for trainees and clinicians seeking to understand modern, function-preserving approaches to oropharyngeal cancer management.

Research Focus

Key Achievements

2
H-Index
2
Papers
29
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Comparative cost of transoral robotic surgery and radiotherapy (IMRT) in early stage tonsil cancer
17 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cardiovascular Medical Group, Kaiser Permanente

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago